abstract |
This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula (I): n nor a form thereof, wherein p, R 1 , R 2 and Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease. |